CADPT09A12201
IPF Study
Study Title
A participant- and investigator-blinded, randomized, placebo-controlled, multicenter, platform study to investigate efficacy, safety, and tolerability of various single treatments in participants with idiopathic pulmonary fibrosis
Study duration
9 months
Number of CLINIC VISITS
9
Main entry criteria
- At least 40 years of age
- Confirmed diagnosis of IPF within the last 5 years
There are additional eligibility requirements to enrol in this study. Our Study Doctor will review the study requirements and discuss your eligibility with you either over the telephone or at your first clinic visit.
Assessments
- Chest CT Scan
- Questionnaires
- Blood pressure and pulse
- ECGs
- Breathing tests
- Blood and urine tests
- 6-Minute Walk Tests
You will receive all study-related procedures, medications, and laboratory services at no cost. In addition, you will be reimbursed $70 per visit for your time and travel.